{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T08:07:58Z","timestamp":1774080478634,"version":"3.50.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10495-026-02259-5","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:58:01Z","timestamp":1769129881000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ILF2 cooperates with ILF3\/KLF16 to drive colorectal cancer progression via modulating the behaviors of both tumor cells and M2 macrophages"],"prefix":"10.1007","volume":"31","author":[{"given":"Dong","family":"Mao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jufeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaowei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7740-4423","authenticated-orcid":false,"given":"Yun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"key":"2259_CR1","unstructured":"(2022) Global, regional, and National burden of colorectal cancer and its risk factors, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. Lancet Gastroenterol Hepatol 7:627\u2013647"},{"key":"2259_CR2","doi-asserted-by":"publisher","first-page":"e13423","DOI":"10.1111\/cpr.13423","volume":"56","author":"DL L","year":"2023","unstructured":"L DL X, P H, et al (2023) Heterogeneity and plasticity of epithelial-mesenchymal transition (EMT) in cancer metastasis: focusing on partial EMT and regulatory mechanisms. Cell Prolif 56:e13423","journal-title":"Cell Prolif"},{"key":"2259_CR3","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1067\/j.cpsurg.2018.08.004","volume":"55","author":"S CL","year":"2018","unstructured":"CL S, S W, K I, et al (2018) Cytoreduction for colorectal metastases: liver, lung, peritoneum, lymph nodes, bone, brain. When does it palliate, prolong survival, and potentially cure? Curr Probl Surg 55:330\u2013379","journal-title":"Curr Probl Surg"},{"key":"2259_CR4","doi-asserted-by":"crossref","unstructured":"JD RC K, C L, et al (2021) The colorectal cancer tumor microenvironment and its impact on liver and lung metastasis. Cancers 13","DOI":"10.3390\/cancers13246206"},{"key":"2259_CR5","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"Q DF","year":"2013","unstructured":"DF Q, JA J (2013) Microenvironmental regulation of tumor progression and metastasis. Nat Med 19:1423\u20131437","journal-title":"Nat Med"},{"key":"2259_CR6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ccell.2017.06.009","volume":"32","author":"SG A L-S","year":"2017","unstructured":"A L-S SG, MJ S, L G (2017) Control of metastasis by NK cells. Cancer Cell 32:135\u2013154","journal-title":"Cancer Cell"},{"key":"2259_CR7","doi-asserted-by":"crossref","unstructured":"L C, JW P. (2020) Tumor-associated macrophages. Curr Biology: CB 30:R246\u2013R248","DOI":"10.1016\/j.cub.2020.01.031"},{"key":"2259_CR8","doi-asserted-by":"crossref","unstructured":"Y S, Y W, R S, et al. (2023) Dual identity of tumor-associated macrophage in regulated cell death and oncotherapy. Heliyon 9:e17582","DOI":"10.1016\/j.heliyon.2023.e17582"},{"key":"2259_CR9","doi-asserted-by":"crossref","unstructured":"A S, K M, SM G, et al. (2023) Colorectal cancer metastases in the liver Establish immunosuppressive Spatial networking between Tumor-Associated SPP1\u2009+\u2009Macrophages and fibroblasts. Clin Cancer Research: official J Am Association Cancer Res 29:244\u2013260","DOI":"10.1158\/1078-0432.CCR-22-2041"},{"key":"2259_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41420-023-01336-x","volume":"9","author":"DL L","year":"2023","unstructured":"L DL X, P H, et al (2023) Cancer-associated fibroblast-secreted IGFBP7 promotes gastric cancer by enhancing tumor associated macrophage infiltration via FGF2\/FGFR1\/PI3K\/AKT axis. Cell Death Discovery 9:17","journal-title":"Cell Death Discovery"},{"key":"2259_CR11","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/s41388-018-0492-9","volume":"38","author":"C LA","year":"2019","unstructured":"LA C, K S, M A, et al (2019) Loss of solute carrier family 7 member 2 exacerbates inflammation-associated colon tumorigenesis. Oncogene 38:1067\u20131079","journal-title":"Oncogene"},{"key":"2259_CR12","doi-asserted-by":"publisher","first-page":"101647","DOI":"10.1016\/j.tranon.2023.101647","volume":"31","author":"J RFA","year":"2023","unstructured":"RFA J, GA L, T S, et al (2023) Retinoic acid-loaded PLGA nanocarriers targeting cell cholesterol potentialize the antitumour effect of PD-L1 antibody by preventing epithelial-mesenchymal transition mediated by M2-TAM in colorectal cancer. Translational Oncol 31:101647","journal-title":"Translational Oncol"},{"key":"2259_CR13","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/cdd.2009.164","volume":"17","author":"G TE","year":"2010","unstructured":"TE G, SD B, PN K, MB M, M H (2010) NF45 functions as an IRES trans-acting factor that is required for translation of cIAP1 during the unfolded protein response. Cell Death Differ 17:719\u2013729","journal-title":"Cell Death Differ"},{"key":"2259_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11010-015-2535-7","volume":"410","author":"W C","year":"2015","unstructured":"C W, C G, L J, et al (2015) NF45 overexpression is associated with poor prognosis and enhanced cell proliferation of pancreatic ductal adenocarcinoma. Mol Cell Biochem 410:25\u201335","journal-title":"Mol Cell Biochem"},{"key":"2259_CR15","doi-asserted-by":"crossref","unstructured":"Q H, X H, X Q, et al. (2014) Expression of NF45 correlates with malignant grade in gliomas and plays a pivotal role in tumor growth. Tumour Biology: J Int Soc Oncodevelopmental Biology Med 35:10149\u201310157","DOI":"10.1007\/s13277-014-2310-5"},{"key":"2259_CR16","doi-asserted-by":"publisher","first-page":"5176","DOI":"10.1038\/onc.2012.533","volume":"32","author":"S RA","year":"2013","unstructured":"RA S, Pe MHT, MB M (2013) Induction of p53, p21 and apoptosis by Silencing the NF90\/NF45 complex in human papilloma virus-transformed cervical carcinoma cells. Oncogene 32:5176\u20135185","journal-title":"Oncogene"},{"key":"2259_CR17","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10735-015-9624-5","volume":"46","author":"GM T N","year":"2015","unstructured":"T N GM, Q X et al (2015) Upregulated expression of ILF2 in non-small cell lung cancer is associated with tumor cell proliferation and poor prognosis. J Mol Histol 46:325\u2013335","journal-title":"J Mol Histol"},{"key":"2259_CR18","doi-asserted-by":"crossref","unstructured":"S C, X J, C D, et al. (2016) Expression and critical role of Interleukin enhancer binding factor 2 in hepatocellular carcinoma. Int J Mol Sci 17","DOI":"10.3390\/ijms17081373"},{"key":"2259_CR19","doi-asserted-by":"crossref","unstructured":"S N, J Z, J Z, et al. (2015) Expression and clinical role of NF45 as a novel cell cycle protein in esophageal squamous cell carcinoma (ESCC). Tumour Biology: J Int Soc Oncodevelopmental Biology Med 36:747\u2013756","DOI":"10.1007\/s13277-014-2683-5"},{"key":"2259_CR20","doi-asserted-by":"publisher","first-page":"e65683","DOI":"10.1371\/journal.pone.0065683","volume":"8","author":"C FH","year":"2013","unstructured":"FH C, HH L, HC L (2013) ToP: a trend-of-disease-progression procedure works well for identifying cancer genes from multi-state cohort gene expression data for human colorectal cancer. PLoS ONE 8:e65683","journal-title":"PLoS ONE"},{"key":"2259_CR21","doi-asserted-by":"crossref","unstructured":"K Y, K P et al (2013) BE R,. Control of tumor-associated macrophage alternative activation by macrophage migration inhibitory factor. Journal of immunology (Baltimore, Md: 1950) 190:2984\u20132993","DOI":"10.4049\/jimmunol.1201650"},{"key":"2259_CR22","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1158\/1541-7786.MCR-19-0204","volume":"18","author":"SA PY","year":"2020","unstructured":"PY SA W, SQ K, et al (2020) PRMT6 promotes lung tumor progression via the alternate activation of tumor-Associated macrophages. Mol Cancer Research: MCR 18:166\u2013178","journal-title":"Mol Cancer Research: MCR"},{"key":"2259_CR23","doi-asserted-by":"publisher","first-page":"4460","DOI":"10.1038\/onc.2014.373","volume":"34","author":"J W","year":"2015","unstructured":"W J, H H, L D, et al (2015) Regulation of cell cycle of hepatocellular carcinoma by NF90 through modulation of Cyclin E1 mRNA stability. Oncogene 34:4460\u20134470","journal-title":"Oncogene"},{"key":"2259_CR24","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1038\/onc.2012.414","volume":"32","author":"H Q","year":"2013","unstructured":"Q H, YY L, H N, et al (2013) Interleukin enhancer-binding factor 3 promotes breast tumor progression by regulating sustained urokinase-type plasminogen activator expression. Oncogene 32:3933\u20133943","journal-title":"Oncogene"},{"key":"2259_CR25","doi-asserted-by":"publisher","first-page":"12441","DOI":"10.1093\/nar\/gkx931","volume":"45","author":"TSSF RP","year":"2017","unstructured":"RP TSSF G, SE B (2017) NF90-NF45 is a selective RNA chaperone that rearranges viral and cellular riboswitches: biochemical analysis of a virus host factor activity. Nucleic Acids Res 45:12441\u201312454","journal-title":"Nucleic Acids Res"},{"key":"2259_CR26","doi-asserted-by":"publisher","first-page":"9356","DOI":"10.1093\/nar\/gks696","volume":"40","author":"W UM","year":"2012","unstructured":"UM W, AG C (2012) NF45 dimerizes with NF90, Zfr and SPNR via a conserved domain that has a nucleotidyltransferase fold. Nucleic Acids Res 40:9356\u20139368","journal-title":"Nucleic Acids Res"},{"key":"2259_CR27","doi-asserted-by":"crossref","unstructured":"F W, Y H, H W, et al. (2023) LncRNA FTO-IT1 promotes Glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2. Journal of experimental & clinical cancer research. CR 42:267","DOI":"10.1186\/s13046-023-02847-2"},{"key":"2259_CR28","doi-asserted-by":"crossref","unstructured":"D L, L S, X Z, et al. (2022) LncRNA ELF3-AS1 inhibits gastric cancer by forming a negative feedback loop with SNAI2 and regulates ELF3 mRNA stability via interacting with ILF2\/ILF3 complex. J Experimental Clin Cancer Research: CR 41:332","DOI":"10.1186\/s13046-022-02541-9"},{"key":"2259_CR29","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1042\/BCJ20160790","volume":"474","author":"TSPKHLSF RP","year":"2017","unstructured":"RP TSPKHLSF G, SE B (2017) The properties of the RNA-binding protein NF90 are considerably modulated by complex formation with NF45. Biochem J 474:259\u2013280","journal-title":"Biochem J"},{"key":"2259_CR30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.18632\/oncotarget.1456","volume":"5","author":"RL K OdB","year":"2014","unstructured":"K OdB RL, O DW FL, P P (2014) Kr\u00fcppel-like factors in cancer progression: three fingers on the steering wheel. Oncotarget 5:29\u201348","journal-title":"Oncotarget"},{"key":"2259_CR31","doi-asserted-by":"crossref","unstructured":"J Z, W Y, X W, B H, D W, G S. (2020) KLF16 affects the MYC signature and tumor growth in prostate cancer. OncoTargets Therapy 13:1303\u20131310","DOI":"10.2147\/OTT.S233495"},{"key":"2259_CR32","doi-asserted-by":"crossref","unstructured":"S B, J L, M Z, et al. (2020) The clinical relevance and function of Kr\u00fcppel-Like factor 16 in breast cancer. Cancer Manage Res 12:6373\u20136383","DOI":"10.2147\/CMAR.S256490"},{"key":"2259_CR33","first-page":"3027","volume":"9","author":"PM CQ","year":"2017","unstructured":"CQ PM, YF S W, et al (2017) KLF16 promotes proliferation in gastric cancer cells via regulating p21 and CDK4. Am J Translational Res 9:3027\u20133036","journal-title":"Am J Translational Res"},{"key":"2259_CR34","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1016\/j.ymthe.2022.04.022","volume":"30","author":"M XD","year":"2022","unstructured":"XD M, SD X, SH H, et al (2022) KLF16 enhances stress tolerance of colorectal carcinomas by modulating nucleolar homeostasis and translational reprogramming. Mol Therapy: J Am Soc Gene Therapy 30:2828\u20132843","journal-title":"Mol Therapy: J Am Soc Gene Therapy"},{"key":"2259_CR35","first-page":"2717","volume":"11","author":"S DP","year":"2021","unstructured":"DP S, YF T, CC L, et al (2021) A novel mechanism driving poor-prognostic gastric cancer: overexpression of the transcription factor Kr\u00fcppel-like factor 16 promotes growth and metastasis of gastric cancer through regulating the Notch pathway. Am J Cancer Res 11:2717\u20132735","journal-title":"Am J Cancer Res"},{"key":"2259_CR36","doi-asserted-by":"crossref","unstructured":"J P, W L, A W, et al. (2021) Long non-coding RNA HOMER3-AS1 drives hepatocellular carcinoma progression via modulating the behaviors of both tumor cells and macrophages. Cell Death Dis 12:1103","DOI":"10.1038\/s41419-021-04309-z"},{"key":"2259_CR37","doi-asserted-by":"publisher","first-page":"C277","DOI":"10.1152\/ajpcell.00341.2011","volume":"302","author":"LL JN","year":"2012","unstructured":"JN LL R, T Z, et al (2012) Activation of Wnt3a signaling stimulates intestinal epithelial repair by promoting c-Myc-regulated gene expression. Am J Physiol Cell Physiol 302:C277\u2013285","journal-title":"Am J Physiol Cell Physiol"},{"key":"2259_CR38","doi-asserted-by":"crossref","unstructured":"L S, M P, C V, et al. (2014) Emerging role of the \u03b2-catenin-PPAR\u03b3 axis in the pathogenesis of colorectal cancer. World J Gastroenterol 20:7137\u20137151","DOI":"10.3748\/wjg.v20.i23.7137"},{"key":"2259_CR39","doi-asserted-by":"crossref","unstructured":"H H, G D, S W, et al. (2023) Long Non-Coding RNA LOC339059 Attenuates IL-6\/STAT3-Signaling-Mediated PDL1 Expression and Macrophage M2 Polarization by Interacting with c-Myc in Gastric Cancer. Cancers 15","DOI":"10.3390\/cancers15225313"},{"key":"2259_CR40","doi-asserted-by":"publisher","first-page":"e608","DOI":"10.1002\/ctm2.608","volume":"11","author":"Z X","year":"2021","unstructured":"X Z, MA B, R G, et al (2021) Interleukin enhancer-binding factor 2 promotes cell proliferation and DNA damage response in metastatic melanoma. Clin Translational Med 11:e608","journal-title":"Clin Translational Med"},{"key":"2259_CR41","doi-asserted-by":"crossref","unstructured":"M Z, Y L, J C, et al. (2019) ILF2 cooperates with E2F1 to maintain mitochondrial homeostasis and promote small cell lung cancer progression. Cancer Biology Med 16:771\u2013783","DOI":"10.20892\/j.issn.2095-3941.2019.0050"},{"key":"2259_CR42","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13046-024-02950-y","volume":"43","author":"X Z","year":"2024","unstructured":"Z X, H H, J H, et al (2024) LINC00571 drives Tricarboxylic acid cycle metabolism in triple-negative breast cancer through HNRNPK\/ILF2\/IDH2 axis. J Experimental Clin Cancer Research: CR 43:22","journal-title":"J Experimental Clin Cancer Research: CR"},{"key":"2259_CR43","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13578-022-00849-9","volume":"12","author":"W Z","year":"2022","unstructured":"Z W, J C, F S, et al (2022) LncRNA CRLM1 inhibits apoptosis and promotes metastasis through transcriptional regulation cooperated with HnRNPK in colorectal cancer. Cell Bioscience 12:120","journal-title":"Cell Bioscience"},{"key":"2259_CR44","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.abb.2018.12.012","volume":"663","author":"TS Y W-J","year":"2019","unstructured":"Y W-J TS, X K-Y, W J-J TJ, W S-H (2019) NF45 promotes esophageal squamous carcinoma cell invasion by increasing Rac1 activity through 14-3-3\u03b5 protein. Arch Biochem Biophys 663:101\u2013108","journal-title":"Arch Biochem Biophys"},{"key":"2259_CR45","doi-asserted-by":"publisher","first-page":"8785","DOI":"10.1080\/21655979.2022.2051886","volume":"13","author":"YC H Z","year":"2022","unstructured":"H Z YC, B X, X W, H L (2022) Serine hydroxymethyltransferase 2 (SHMT2) potentiates the aggressive process of oral squamous cell carcinoma by binding to Interleukin enhancer-binding factor 2 (ILF2). Bioengineered 13:8785\u20138797","journal-title":"Bioengineered"},{"key":"2259_CR46","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12916-015-0278-7","volume":"13","author":"FC X","year":"2015","unstructured":"X FC Z, L L, et al (2015) New horizons in tumor microenvironment biology: challenges and opportunities. BMC Med 13:45","journal-title":"BMC Med"},{"key":"2259_CR47","doi-asserted-by":"crossref","unstructured":"T C, P O, K K, N I. (2014) Tumor-associated macrophages as major players in the tumor microenvironment. Cancers 6:1670\u20131690","DOI":"10.3390\/cancers6031670"},{"key":"2259_CR48","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","volume":"41","author":"M PJ","year":"2014","unstructured":"PJ M, JE A, SK B et al (2014) Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 41:14\u201320","journal-title":"Immunity"},{"key":"2259_CR49","doi-asserted-by":"crossref","unstructured":"S G, FO M. (2010) Alternative activation of macrophages: mechanism and functions. Immunity 32:593\u2013604","DOI":"10.1016\/j.immuni.2010.05.007"},{"key":"2259_CR50","first-page":"8901326","volume":"2022","author":"NA C","year":"2022","unstructured":"C NA Y, M A, et al (2022) Understanding of immune escape mechanisms and advances in cancer immunotherapy. J Oncol 2022:8901326","journal-title":"J Oncol"},{"key":"2259_CR51","doi-asserted-by":"crossref","unstructured":"R H, T K, S C. (2024) The role of tumor-associated macrophages in tumor immune evasion. J Cancer Res Clin Oncol 150:238","DOI":"10.1007\/s00432-024-05777-4"},{"key":"2259_CR52","doi-asserted-by":"crossref","unstructured":"J Z, H L, S Z, et al. (2021) Epigenetic Silencing of miR-144\/451a cluster contributes to HCC progression via paracrine HGF\/MIF-mediated TAM remodeling. Mol Cancer 20:46","DOI":"10.1186\/s12943-021-01343-5"},{"key":"2259_CR53","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12943-022-01616-7","volume":"21","author":"TM H Z","year":"2022","unstructured":"H Z TM, S T, et al (2022) Wnt signaling in colorectal cancer: pathogenic role and therapeutic target. Mol Cancer 21:144","journal-title":"Mol Cancer"},{"key":"2259_CR54","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.trecan.2017.05.003","volume":"3","author":"P B","year":"2017","unstructured":"B P, M B, R A (2017) RNA-Binding proteins in cancer: old players and new actors. Trends Cancer 3:506\u2013528","journal-title":"Trends Cancer"},{"key":"2259_CR55","doi-asserted-by":"crossref","unstructured":"H Q, H N, Y L, et al. (2020) RNA-binding proteins in tumor progression. J Hematol Oncol 13:90","DOI":"10.1186\/s13045-020-00927-w"},{"key":"2259_CR56","doi-asserted-by":"crossref","unstructured":"X LL Z, Y L, et al (2022) Transcription factor KLF16 activates MAGT1 to regulate the tumorigenesis and progression of breast cancer. Int J Mol Med 50","DOI":"10.3892\/ijmm.2022.5171"},{"key":"2259_CR57","doi-asserted-by":"crossref","unstructured":"L Z, J W, S H, et al. (2024) The KLF16\/MYC feedback loop is a therapeutic target in bladder cancer. J Experimental Clin Cancer Research: CR 43:303","DOI":"10.1186\/s13046-024-03224-3"},{"key":"2259_CR58","doi-asserted-by":"crossref","unstructured":"H D, Y L, F S, K L, Y X. (2019) ILF2 Directly Binds and Stabilizes CREB to Stimulate Malignant Phenotypes of Liver Cancer Cells. Analytical cellular pathology (Amsterdam) 2019:1575031","DOI":"10.1155\/2019\/1575031"},{"key":"2259_CR59","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41392-021-00701-5","volume":"6","author":"Y F","year":"2021","unstructured":"F Y, C Y, F L, et al (2021) Wnt\/\u03b2-catenin signaling in cancers and targeted therapies. Signal Transduct Target Therapy 6:307","journal-title":"Signal Transduct Target Therapy"},{"key":"2259_CR60","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1158\/0008-5472.CAN-24-3841","volume":"85","author":"PA M EG","year":"2025","unstructured":"M EG PA, E MC (2025) AXL tyrosine kinases: a growing isoform family that promotes cancer pathogenesis. Cancer Res 85:2561\u20132573","journal-title":"Cancer Res"},{"key":"2259_CR61","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.devcel.2009.06.016","volume":"17","author":"M BT","year":"2009","unstructured":"BT M, K T, X H (2009) Wnt\/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17:9\u201326","journal-title":"Dev Cell"},{"key":"2259_CR62","doi-asserted-by":"crossref","unstructured":"H X, L L, W L, et al. (2021) Transcription factors in colorectal cancer: molecular mechanism and therapeutic implications. Oncogene 40:1555\u20131569","DOI":"10.1038\/s41388-020-01587-3"},{"key":"2259_CR63","unstructured":"P H, N A, M B, et al. (2016) Screening out irrelevant cell-based models of disease"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02259-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10495-026-02259-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02259-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T07:05:04Z","timestamp":1774076704000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10495-026-02259-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2259"],"URL":"https:\/\/doi.org\/10.1007\/s10495-026-02259-5","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"27 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the First Affiliated Hospital of Jinzhou Medical University. Informed consent was obtained from enrolled patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors and patients have agreed to publish this research article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"52"}}